Related Experiment Video
Updated: Dec 3, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Pathogenesis guided therapeutic management of COVID-19: an immunological perspective
Ashutosh Kumar1,2, Pranav Prasoon1,3, Prakash S Sekhawat1,4
1Etiologically Elusive Disorders Research Network (EEDRN), New Delhi, India.
Abstract:
Lack of standardized therapeutic approaches is arguably the significant contributor to the high burden of mortality observed in the ongoing pandemic of the Coronavirus disease, 2019 (COVID-19). Evidence is accumulating on SARS-CoV-2 specific immune cell dysregulation and consequent tissue injury in COVID-19. Currently, no definite drugs or vaccines are available against the disease; however initial results of the ongoing clinical trials have raised some hope. In this article, taking insights from the emerging empirical evidence about host-virus interactions, we deliberate upon plausible pathogenic mechanisms and suitable therapeutic approaches for COVID-19.
Insights
The Coronavirus disease 2019 (COVID-19) pandemic has high mortality due to non-standardized treatments. This review explores host-virus interactions, pathogenic mechanisms, and potential therapeutic strategies for COVID-19.
Area of Science:
- Immunology
- Virology
- Pathology
Background:
- The Coronavirus disease 2019 (COVID-19) pandemic presents a significant global health challenge, characterized by high mortality rates.
- A primary driver of this mortality is the lack of standardized therapeutic interventions.
- Emerging evidence highlights SARS-CoV-2-induced immune cell dysregulation and subsequent tissue damage as key pathological features.
Purpose of the Study:
- To review the current understanding of host-virus interactions in COVID-19.
- To deliberate on the plausible pathogenic mechanisms underlying COVID-19.
- To identify and discuss suitable therapeutic approaches for managing COVID-19.
Main Methods:
- Literature review of empirical evidence on host-virus interactions.
- Analysis of emerging data on immune cell dysregulation and tissue injury in COVID-19.
- Synthesis of information to propose pathogenic mechanisms and therapeutic strategies.
Main Results:
- Accumulating evidence points to specific immune cell dysregulation as a critical factor in COVID-19 pathogenesis.
- Tissue injury is a direct consequence of the host's immune response to SARS-CoV-2 infection.
- While no definitive treatments exist, ongoing clinical trials show promising initial results.
Conclusions:
- Understanding host-virus interactions is crucial for developing effective COVID-19 therapies.
- Targeting immune dysregulation and mitigating tissue injury are key therapeutic considerations.
- Further research into standardized treatment protocols is essential to reduce COVID-19 mortality.
More Related Videos
07:36Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection
Published on: February 28, 2021
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Microorganisms in Medicine and Therapeutics
Myocarditis III: Medical Management
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...